Jeremy Grantham and Edward Chancellor, Owen Lamont, Aswath Damodaran, Peter Oppenheimer...in the latest edition of my Markets A.M. newsletter, I look at some of the luminaries who have weighed in ...

OpenAI, Anthropic, and SpaceX IPOs may put pressure on the stock market in 2026, GMO says. The firm predicts that increased IPO activity could pull money away from the rest of the market. The firm has ...

Welcome to the award-winning Money Distilled newsletter. I’m John Stepek. Every week day I look at the biggest stories in markets and economics, and explain what it all means for your money. There’s ...

The veteran investor compared the AI boom to the internet and railroad manias of the past. The "probabilities that AI will not bust are slim to none," Grantham said. Jeremy Grantham says AI is one of ...

For more than four decades, Jeremy Grantham has been one of the most contrarian voices in global investing. The co-founder of Boston-based asset manager GMO, he built his reputation warning about ...

U.S. equity markets continued their constructive start to 2026, with broad participation across styles, sectors, and market capitalizations. The top performing mini-sector index ETFs thus far are ...

Buy low, sell high, get rich. Jeremy Grantham’s Wall Street career exactly conforms to this charmed sequence, but with what troubles along the way. The reader, at least, will be glad for them. They ...

Jeremy Grantham was born toward the tail end of the Great Depression, but has surfed plenty of subsequent booms and busts in his storied investment career. He recounts the experience, with wit and ...

As Bruce Springsteen’s manager Jon Landau in Deliver Me From Nowhere, and soon Mark Zuckerberg, Strong burrows into his characters with total conviction. Strong wears a Tom Ford shirt. Strong wears a ...

Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...

Jeremy Grantham, the co-founder and long-term investment strategist of Boston-based GMO, has a well-earned reputation as a savvy value investor. It wasn’t always thus. Fairly early in his lengthy ...